New Markers of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Sweat (NCT03993600) | Clinical Trial Compass
UnknownNot Applicable
New Markers of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Sweat
Belgium30 participantsStarted 2018-12-04
Plain-language summary
The aim of the study is to identify new biomarkers of CFTR function in sweat and in sweat gland.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject aged of 18 years or more.
* The patients with cystic fibrosis must have a confirmed diagnosis, be clinically stable, have a Forced Expiratory Volume in one second (FEV1) ≥ 30 and an O2 saturation ≥ 92%. F508del homozygous will been tested.
* Heterozygosity (parents of patients) will be confirmed by the presence of a single F508del mutation.
Exclusion Criteria:
* Presence of an acute infection
* Pregnancy and lactation
* Subjects currently included in another clinical trial
* Subjects with forearm skin alterations
* Subjects with signs of dehydration
* Smokers